Pfizer PFE
$
Relative Strength Index (RSI)
- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.
- The RSI is calculated using the following formula:
RSI = 100 - (100 / (1 + RS))
Where RS is the ratio of the average gains to the average losses over a specified period.
- The default time period used is 14 days.
- RSI values range between 0 and 100.
RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)
RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)
RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.
Key Insights
Pfizer (PFE) Core Market Data and Business Metrics
Latest Closing Price
$24.7Price-Earnings Ratio
17.52Total Outstanding Shares
5.67 Billion SharesDividend
$0.43 Per Share QuarterlySIC Description
Pharmaceutical PreparationsPrimary Exchange
New York Stock ExchangeHeadquarters
66 Hudson Boulevard East, New York, NY, 10001-2192
Historical Stock Splits
| Execution Date | Split Amount |
|---|---|
| No Historical Stock Splits | |
Short Interest
Track Short Interest Levels to Gauge Bearish Market Sentiment and Short Squeeze Potential
| Avg Daily Volume | Days to Cover | Settlement Date | Short Interest |
|---|---|---|---|
| 44,596,409 Shares | 2.22 | 3/14/2025 | 99,172,324 Shares |
| 40,758,814 Shares | 2.33 | 2/28/2025 | 94,955,194 Shares |
| 42,222,092 Shares | 2.11 | 2/14/2025 | 89,117,210 Shares |
| 37,688,065 Shares | 1.95 | 1/31/2025 | 73,568,473 Shares |
| 33,747,882 Shares | 2.72 | 1/15/2025 | 91,783,778 Shares |
| 46,147,044 Shares | 1.64 | 12/31/2024 | 75,709,116 Shares |
Cash Flow Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Exchange Gains/Losses | $-66 Million |
| Net Cash Flow | $-1.81 Billion |
| Net Cash Flow From Investing Activities | $2.65 Billion |
| Net Cash Flow From Investing Activities, Continuing | $2.65 Billion |
| Net Cash Flow From Financing Activities, Continuing | $-17.14 Billion |
| Net Cash Flow From Operating Activities, Continuing | $12.74 Billion |
Income Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Income Tax Expense/Benefit | $-28 Million |
| Net Income/Loss Attributable To Noncontrolling Interest | $31 Million |
| Net Income/Loss Available To Common Stockholders, Basic | $8.03 Billion |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0 |
| Interest Expense, Operating | $3.09 Billion |
| Cost Of Revenue | $17.85 Billion |
Comprehensive Income
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Comprehensive Income/Loss | $8.18 Billion |
| Other Comprehensive Income/Loss | $116 Million |
| Comprehensive Income/Loss Attributable To Parent | $8.15 Billion |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $28 Million |
Balance Sheet
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Liabilities | $124.90 Billion |
| Fixed Assets | $18.39 Billion |
| Current Liabilities | $42.99 Billion |
| Other Current Assets | $39.51 Billion |
| Noncurrent Liabilities | $81.90 Billion |
| Equity Attributable To Noncontrolling Interest | $294 Million |
Historical Dividends
Current dividend: $0.43 Per Share Quarterly
| Announcement Date | Payment Date | Record Date | Amount | Frequency |
|---|---|---|---|---|
| Dec 12, 2024 | Mar 7, 2025 | Jan 24, 2025 | $0.43 | Quarterly |
| Oct 9, 2024 | Dec 2, 2024 | Nov 8, 2024 | $0.42 | Quarterly |
| Jun 26, 2024 | Sep 3, 2024 | Jul 26, 2024 | $0.42 | Quarterly |
| Apr 24, 2024 | Jun 14, 2024 | May 10, 2024 | $0.42 | Quarterly |
| Dec 14, 2023 | Mar 1, 2024 | Jan 26, 2024 | $0.42 | Quarterly |
| Oct 4, 2023 | Dec 4, 2023 | Nov 10, 2023 | $0.41 | Quarterly |